title: Vancomycin-resistant enterococcus infection is a rare complication in patients receiving PD on an outpatient basis.
authors.affiliation: Department of Medicine, Lenox Hill Hospital, New York, New York, USA.
authors.forename: R
authors.initials: R
authors.lastname: Ng
authors.forename: P M
authors.initials: PM
authors.lastname: Zabetakis
authors.forename: C
authors.initials: C
authors.lastname: Callahan
authors.forename: R
authors.initials: R
authors.lastname: Krapf
authors.forename: C
authors.initials: C
authors.lastname: Sasak
authors.forename: S
authors.initials: S
authors.lastname: Fritzsch
authors.forename: A
authors.initials: A
authors.lastname: Pollock
authors.forename: P
authors.initials: P
authors.lastname: Balter
authors.forename: M F
authors.initials: MF
authors.lastname: Michelis
mesh_terms: D000554:Ambulatory Care Facilities; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology; D013212:Staphylococcus epidermidis; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin